drugset / Trial / NCT00049140

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

NCT00049140

NaSingle-groupOpen-labelDiagnostic

Summary

RATIONALE: Diagnostic procedures using the drug EF5 to detect the presence of oxygen in tumor cells may help to plan effective treatment for solid tumors. PURPOSE: Phase II trial to compare diagnostic procedures using EF5 to that of other methods of detecting oxygen levels in tumor cells of patients who have head and neck cancer.

Timeline

Start
2002-08
Primary completion
2004-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject EF5 Diagnostic / imaging agent Intravenous

Indications